Medical Devices Investors & VC Firms
1393 firms in this list, with a median first check of $500K. 266 of them lead rounds. Generated from verified public data and updated continuously.
Time BioVentures
Southern CaliforniaSeed–Series A
17 people
Triventures
HerzliyaPre-Seed–Series A$1M – $3M
11 people
Bioventures Investors
WestboroughSeed–Late Stage$15M – $100M
15 people
Co-Win Ventures
SuzhouSeed–Series B
Cove Fund
IrvinePre-Seed–Series A$250K – $1M
12 people
Crescent Capital Partners
SydneySeries A–Late Stage$13.2M – $52.8M
18 people
Enterprise Investors Sp. z o. o.
WarsawSeries A–Growth$21.6M – $81M
24 people
Lewis & Clark Ventures
St. LouisSeed–Series A$2M – $3M
12 people
Revelation Partners
SausalitoGrowth–Late Stage$5M – $50M
17 people
Tattarang
NedlandsSeed–Growth
17 people
Axial VC
San FranciscoPre-Seed–Series A$100K – $5M
2 people
CAP HORN VC
ParisPre-Seed–Series A$1.1M – $22M
4 people
Intuitive Ventures
SunnyvaleSeed–Series A
16 people
QUBIS
BelfastPre-Seed–Series A$12.7K – $127K
11 people
Xeraya Capital
Kuala LumpurSeed–Growth
20 people
Kinled Holding
Hong KongSeed–Series A
1 person
Visionary Ventures
Newport BeachSeries A–Late Stage$5M – $15M
13 people
Foreground Capital
BostonPre-Seed–Series B
9 people
LBBW Venture Capital GmbH
StuttgartSeed–Late Stage$540K – $3.2M
9 people
PsyMed Ventures
BerkeleyPre-Seed–Series A
12 people
MBX Capital
ClaymontPre-Seed–Series A$250K – $2.5M
5 people
TAU Ventures
Tel AvivPre-Seed–Series A$1M – $28M
8 people
FREEFLOW
BerkeleyPre-Seed–Series B
10 people
Okapi Venture Capital
Newport BeachPre-Seed–Series A$750K – $3M
4 people
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.








































































